ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1884

Which Cell Pattern in Immunological Bronchoalveolar Lavage (BAL) Is Associated with a High-resolution Computer Tomography (HRCT) Pattern at the Onset of Inflammatory Rheumatic Disease with Interstitial Lung Disease?

tobias Hoffmann1, Martin Förster2, Peter Oelzner1, Claus Kroegel2, Ulf Teichgräber3, Diane Renz4, Joachim Böttcher1, Christian Schulze2, Gunter Wolf1, Marcus Franz2 and Alexander Pfeil1, 1Department of Internal Medicine III, Jena University Hospital – Friedrich Schiller University Jena, Jena, Germany, 2Department of Internal Medicine I, Jena University Hospital – Friedrich Schiller University Jena, Jena, Germany, 3Institute of Diagnostic and Interventional Radiology, Jena University Hospital – Friedrich Schiller University Jena, Jena, Germany, 4Institute of Diagnostic and Interventional Radiology, Department of Pediatric Radiology, Hannover Medical School, Hannover, Germany

Meeting: ACR Convergence 2023

Keywords: autoimmune diseases, Computed tomography (CT), interstitial lung disease

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1862–1894) Imaging of Rheumatic Diseases Poster II

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Inflammatory rheumatic diseases (IRD) are associated with interstitial lung disease (ILD). High-resolution Computer Tomography (HRCT) is recommended as goldstandard in the detection of IRD-ILD. The main HRCT-pattern included ground-glass opacities (GGO), non-specific interstitial pneumonia (NSIP), usual interstitial pneumonia (UIP), granuloma and cryptogenic organizing pneumonia (COP). Further, bronchoalveolar lavage (BAL) can be used to evaluate pulmonal cell pattern. The aim of this study was to evaluate HRCT pattern at the onset of IRD-ILD and to correlate the HRCT pattern to immunological BAL pattern.

Methods: The study includes 61 patients (connective tissue disease n=39, myositis n=9, vasculitis n=10 and rheumatoid arthritis n=3) with newly diagnosed IRD and evidence of ILD on HRCT. In addition to HRCT, immunological BAL was performed. The American Thoracic Society Clinical Practice Guideline were used to define BAL pattern with lymphocytic cellular pattern ( >15% lymphocytes), neutrophilic cellular pattern ( > 3% neutrophils), eosinophilic cellular pattern ( >1% eosinophils) and unspecific cellular pattern. No patient received any immunosuppressive therapy.

Results: For the total study cohort, the main HRCT pattern were NSIP (44.3%) and GGO (31.3%), followed by UIP (14.8%), granuloma (4.9%) and COP (3.3%). BAL pattern showed the following distribution: 37.7% lymphocytic cellular pattern, 27.9% neutrophilic cellular pattern, 18.0% eosinophilic cellular pattern and 16.4% unspecific cellular pattern. Concerning GGO, the main BAL pattern was lymphocytic cellular pattern (47.4%), whereas neutrophilic cellular pattern (37.0%) and lymphocytic cellular pattern (25.9%) were the dominant pattern in NSIP. UIP revealed the following BAL pattern: lymphocytic cellular pattern 55.6%, neutrophilic cellular pattern 33.3% and unspecific cellular pattern 11.1%.

Conclusion: GGO in HRCT is associated with the occurrence of a lymphocytic pattern in BAL, whereas in NSIP and UIP pattern the lymphocytic and neutophilic pattern is equally expressed. Based on the data, a further leading evaluation should be made with regard to the therapeutic options (anti-inflammatory and / or anti-fibrotic therapy) as well as the prognosis of IRD-ILD.


Disclosures: t. Hoffmann: None; M. Förster: None; P. Oelzner: None; C. Kroegel: None; U. Teichgräber: None; D. Renz: None; J. Böttcher: None; C. Schulze: None; G. Wolf: None; M. Franz: None; A. Pfeil: None.

To cite this abstract in AMA style:

Hoffmann t, Förster M, Oelzner P, Kroegel C, Teichgräber U, Renz D, Böttcher J, Schulze C, Wolf G, Franz M, Pfeil A. Which Cell Pattern in Immunological Bronchoalveolar Lavage (BAL) Is Associated with a High-resolution Computer Tomography (HRCT) Pattern at the Onset of Inflammatory Rheumatic Disease with Interstitial Lung Disease? [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/which-cell-pattern-in-immunological-bronchoalveolar-lavage-bal-is-associated-with-a-high-resolution-computer-tomography-hrct-pattern-at-the-onset-of-inflammatory-rheumatic-disease-with-interstitia/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/which-cell-pattern-in-immunological-bronchoalveolar-lavage-bal-is-associated-with-a-high-resolution-computer-tomography-hrct-pattern-at-the-onset-of-inflammatory-rheumatic-disease-with-interstitia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology